American Diabetes Association Announces Eight Recipients of 2017 National Scientific and Health Care Achievement Awards

Contact

Michelle Kirkwood
press@diabetes.org
703-299-2053

Alexandria, Virginia
April 25, 2017

Top researchers, clinicians and educators will be recognized at the 77th Scientific Sessions for their outstanding leadership and work to advance diabetes research, prevention, care and treatment

The American Diabetes Association (Association), the nation’s leading organization committed to fighting diabetes by driving discovery through research and innovation, by intensifying the urgency around the diabetes epidemic and by supporting people living with and affected by diabetes, is proud to announce this year’s recipients of the Association’s National Scientific and Health Care Achievement awards. Individually and collectively, their exemplary leadership, mentorship and many achievements have advanced the field of diabetes care and improved health outcomes for people with diabetes. 

“Each of the recipients of our National Scientific and Health Care Achievement awards has made an incredible contribution in their respective fields to  increase the  vast library of knowledge that has contributed to the  many scientific and technological advances that has improved the lives of  millions of people living with diabetes,” said William T. Cefalu, MD, Chief Scientific, Medical and Mission Officer of the Association. “As an Association, it is an honor for us to recognize these individuals for their extraordinary work.”

The following leaders will be recognized and will receive their awards at the Association’s 77th Scientific Sessions, June 9-13, 2017 at the San Diego Convention Center. Several award winners will present award lectures, as noted.

Banting Medal for Scientific Achievement

Domenico Accili, MD

Russell Berrie Foundation Professor of Diabetes, Chief of the Endocrinology Division and Director of the Diabetes Research Center at Columbia University College of Physicians and Surgeons, New York

Banting Medal Lecture: The New Biology of Diabetes, Sunday, June 11

Outstanding Scientific Achievement Award

Gregory R. Steinberg, PhD

Professor of Medicine, Canada Research Chair and J. Bruce Duncan Endowed Chair in Metabolic Diseases, and Co-Director of the Metabolism and Childhood Obesity Research Program at McMaster University, Ontario, Canada

Outstanding Scientific Achievement Award Lecture: Energy Sensing and Metabolism: Implications for Treating Diabetes, Monday, June 12

Albert Renold Award

Daryl K. Granner, MD

Professor Emeritus of Molecular Physiology and Biophysics at Vanderbilt University, Nashville, Tenn. and Professor Emeritus of Molecular Physiology and Biophysics and of Internal Medicine at the University of Iowa, Iowa City, Iowa

Outstanding Achievement in Clinical Diabetes Research Award

William V. Tamborlane, MD

Professor and Chief of Pediatric Endocrinology at Yale University and Deputy Director of the Yale Center for Clinical Investigation, New Haven, Conn.

Outstanding Educator in Diabetes Award

Davida F. Kruger, MSN, APRN-BC, BC-ADM

Certified nurse practitioner in diabetes research and clinical practice at Henry Ford Health System, Detroit

Outstanding Educator in Diabetes Award Lecture: A Toast To Our History, Saturday, June 10

Outstanding Physician Clinician in Diabetes Award

Ruth S. Weinstock, MD, PhD

Distinguished Service Professor and Division Chief of Endocrinology, Diabetes and Metabolism at the State University of New York (SUNY) Upstate Medical University and Medical Director of the Clinical Research Unit and Medical Director of the Joslin Diabetes Center at Upstate Medical University, Syracuse, NY

Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes

Roger S. Mazze, PhD

Past head of the World Health Organization Collaborating Center (a joint program of the International Diabetes Center and Mayo Clinic), Clinical Professor, University of Minnesota Medical School (retired), and Visiting Professor, Nanjing Medical University, Nanjing, China

Kelly West Award for Outstanding Achievement in Epidemiology

Dana Dabelea, MD, PhD

Conrad Riley Endowed Professor at the Colorado School of Public Health, Aurora, Colo.

Kelly West Award Lecture: Diabetes in Youth: Looking Backwards to Inform the Future, Sunday, June 11

The American Diabetes Association’s 77th Scientific Sessions, to be held June 9-13, 2017, at the San Diego Convention Center, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, health care professionals have exclusive access to more than 2,500 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight interest areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Brenda Montgomery, RN, MSHS, CDE, President of Health Care and Education¹, will deliver her address on Saturday, June 10, and Alvin C. Powers, MD, President of Medicine and Science, will present his address on Sunday, June 11. Eight abstracts were selected by the Scientific Sessions Meeting Planning Committee to be presented on Tuesday, June 13, in the President’s Oral Session. These abstracts represent important research being conducted in the field of diabetes today. In total, the 2017 Scientific Sessions includes 378 abstracts in 49 oral sessions; 2,152 poster presentations including 50 moderated poster discussions; and 360 published-only abstracts.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)

1 Disclosures for Brenda Montgomery. Employer: AstraZeneca Pharmaceuticals. Montgomery's role as President, Health Care & Education of the American Diabetes Association (Association) is a voluntary position to which she was elected by the members of the Association in 2015. She continues to recuse herself from any and all discussions, decisions or votes that have or could be perceived as having a conflict of interest with her employer.